NEXTSOURCE BIOTECHNOLOGY
Live / Registered — Registered (as of 18 Oct 2022)
What this means for you
Registered since 18 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97035910
- Registration number
- 6876723
- Mark type
- Word mark
- Filed
- 20 Sept 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 18 Oct 2022
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for human and veterinary use, namely, medications for use in the treatment of oncological, cardiological, neurological, dermatological, ophthalmological, and internal medical conditions; anesthetics for surgical use
Owner
- AZURITY PHARMACEUTICALS, INC., WOBURN, MA, US
- NextSource Biotechnology, LLC, Miami, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
- NextSource Biotechnology, LLC, Miami, FL, US
Prosecution history
- 05 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 May 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 18 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2022 — PUBLISHED FOR OPPOSITION
- 13 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2022 — EXAMINER'S AMENDMENT ENTERED
- 24 Jun 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Jun 2022 — EXAMINERS AMENDMENT E-MAILED